Makana Therapeutics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Makana Therapeutics General Information

Description

Provider of xenotransplantation services intended to solve the organ shortage. The company focuses on commercializing a pipeline of transplantable cells, tissues, and organs for the kidney, heart, lung, liver, blood, and pancreatic islets, enabling patients to provide an abundant supply of donor organs.

Contact Information

Formerly Known As
Xenobridge
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 370 North East 72nd Terrace
  • Miami, FL 33138
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 370 North East 72nd Terrace
  • Miami, FL 33138
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Makana Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC Completed Pre-Clinical Trials
1. Grant 15-Sep-2021 Completed Pre-Clinical Trials
To view Makana Therapeutics’s complete valuation and funding history, request access »

Makana Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of xenotransplantation services intended to solve the organ shortage. The company focuses on commercializing a
Biotechnology
Miami, FL

Cambridge, MA
 

Blacksburg, VA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Makana Therapeutics Competitors (3)

One of Makana Therapeutics’s 3 competitors is Egenesis, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Egenesis Venture Capital-Backed Cambridge, MA
Revivicor Formerly VC-backed Blacksburg, VA
United Therapeutics Formerly VC-backed Silver Spring, MD
You’re viewing 3 of 3 competitors. Get the full list »

Makana Therapeutics Patents

Makana Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4837130-A1 Crossmatching products and methods Pending 31-Dec-2024
AU-2025257802-A1 Products and methods relating to transplant recipient antibodies bound to donor cell membrane fragments Pending 18-Apr-2024
WO-2025221920-A1 Products and methods relating to transplant recipient antibodies bound to donor cell membrane fragments Pending 18-Apr-2024
AU-2024416329-A1 Crossmatching products and methods Pending 05-Jan-2024
WO-2025147461-A1 Crossmatching products and methods Inactive 05-Jan-2024 A61P37/06
To view Makana Therapeutics’s complete patent history, request access »

Makana Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
KidneyX Accelerator/Incubator
Edge (Onalaska) Corporate Venture Capital
To view Makana Therapeutics’s complete investors history, request access »

Makana Therapeutics FAQs

  • When was Makana Therapeutics founded?

    Makana Therapeutics was founded in 2009.

  • Where is Makana Therapeutics headquartered?

    Makana Therapeutics is headquartered in Miami, FL.

  • What industry is Makana Therapeutics in?

    Makana Therapeutics’s primary industry is Biotechnology.

  • Is Makana Therapeutics a private or public company?

    Makana Therapeutics is a Private company.

  • What is Makana Therapeutics’s current revenue?

    The current revenue for Makana Therapeutics is .

  • Who are Makana Therapeutics’s investors?

    KidneyX and Edge (Onalaska) have invested in Makana Therapeutics.

  • Who are Makana Therapeutics’s competitors?

    Egenesis, Revivicor, and United Therapeutics are competitors of Makana Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process